Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
C&F Financial | CFFI | Mar 27, 2024 | 48.50 | +1.83 |
C.H. Robinson Worldwide | CHRW | Mar 27, 2024 | 74.32 | +2.05 |
C3.ai | AI | Mar 27, 2024 | 27.26 | +0.74 |
C3is | CISS | Mar 27, 2024 | 0.04 | -20.58 |
C4 Therapeutics | CCCC | Mar 27, 2024 | 8.05 | +1.39 |
Cabaletta Bio | CABA | Mar 27, 2024 | 17.15 | +1.12 |
Cabana Target Drawdown 10 ETF | TDSC | Mar 27, 2024 | 24.22 | +1.04 |
Cabana Target Drawdown 7 ETF | TDSB | Mar 27, 2024 | 22.05 | +0.68 |
Cable One | CABO | Mar 27, 2024 | 424.98 | -2.46 |
Cabot | CBT | Mar 27, 2024 | 91.85 | +2.60 |
CACI International A | CACI | Mar 27, 2024 | 378.89 | +1.15 |
Cactus A | WHD | Mar 27, 2024 | 49.80 | +0.38 |
Cactus Acquisition 1 A | CCTS | Mar 27, 2024 | 11.10 | 0.00 |
Cadeler ADR | CDLR | Mar 27, 2024 | 18.92 | 0.00 |
Cadence Bank | CADE | Mar 27, 2024 | 28.94 | +4.51 |
Cadence Bank A | CADE-A | Mar 27, 2024 | 20.77 | +1.37 |
Cadence Design Systems | CDNS | Mar 27, 2024 | 311.34 | -1.48 |
Cadiz | CDZI | Mar 27, 2024 | 2.60 | +2.77 |
Cadiz Pref ADR | CDZIP | Mar 27, 2024 | 14.15 | +1.07 |
Cadre | CDRE | Mar 27, 2024 | 35.81 | +0.51 |
Cadrenal Therapeutics | CVKD | Mar 27, 2024 | 0.64 | -1.33 |
Cae | CAE | Mar 27, 2024 | 20.50 | +0.84 |
Caesars Entertainment | CZR | Mar 27, 2024 | 43.36 | +1.52 |
Caesarstone | CSTE | Mar 27, 2024 | 4.07 | 0.00 |
Cal-Maine Foods | CALM | Mar 27, 2024 | 58.62 | -1.41 |
Calamos Convertible High Fund | CHY | Mar 27, 2024 | 11.86 | -0.25 |
Calamos Convertible Opportunities And Income Fund | CHI | Mar 27, 2024 | 11.39 | -0.44 |
Calamos Dynamic Convertible & Income Fund | CCD | Mar 27, 2024 | 21.97 | -0.36 |
Calamos Global Dynamic Fund | CHW | Mar 27, 2024 | 6.53 | +0.31 |
Calamos Global Total Return Fund | CGO | Mar 27, 2024 | 10.42 | +0.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.